Beijing Biostar Pharmaceuticals Co., Ltd.

Quick facts

Phase 3 pipeline

• UTD1 Injection plus capecitabine · Oncology
  UTD1 Injection plus capecitabine works by targeting and inhibiting the action of certain enzymes involved in DNA synthesis, thereby inhibiting cancer cell growth.

Phase 2 pipeline

• Fluoropyrimidine- and Platinum-containing Therapy · Oncology
  Fluoropyrimidine- and Platinum-containing Therapy works by interfering with DNA replication and transcription, ultimately leading to cell death.
• Utidelone combined with Bevacizumab

Phase 1 pipeline

• Utidelone Injection; capecitabine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Beijing Biostar Pharmaceuticals Co., Ltd. portfolio CI brief
• Beijing Biostar Pharmaceuticals Co., Ltd. pipeline updates RSS